Main > A1. CORP. INDEX. R-Rm > Revance Therapeutics/P C2

---

This data is not available for free

Revance Therapeutics/P C2's subsections
2012. 10.08. Regains WW Rights
2013. 04.02. Financing
2022. 09.08. FDA Approval
2023. 08.14. FDA Approval
2024. 05.09. USA Launch
Web-Site

Revance Therapeutics/P C2's products
This section has no products